Clinical outcomes of patients with idiopathic MN according to anti-PLA2R levels.

MN, membranous nephropathy; Anti-PLA2R, anti-phospholipase A2 receptor antibody; N, number of patients.aGroup of patients whose serum samples showed anti-PLA2R reactivity at dilutions of 1∶25 or 1∶100 with negative results at dilutions over 1∶100; bGroup of patients whose serum samples showed anti-PLA2R reactivity at dilutions of 1∶500 or 1∶2000 with negative results at dilutions over 1∶2000; cGroup of patients whose serum samples showed anti-PLA2R reactivity at dilutions up to 1∶8000.